Matches in SemOpenAlex for { <https://semopenalex.org/work/W4205156728> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W4205156728 endingPage "151934" @default.
- W4205156728 startingPage "151934" @default.
- W4205156728 abstract "Takayasu arteritis (TA) is a chronic and relapsing vasculitis. The objectives of this study were to describe the characteristics and identify predictive factors associated with successful treatment discontinuation in a cohort of patients with TA.We conducted a retrospective monocentric analysis of patients with TA, followed at the tertiary Vasculitis Clinic in Toronto, from inception to January 2021, and for at least 2 years after diagnosis. The objectives were to determine the frequency of patients whose immunosuppressive medications had been stopped for at least 6 months before their last follow-up visit and whose disease remained inactive, and analyze their characteristics, in comparison with the remaining of the cohort still on medications for TA.The cohort included 65 patients (95.4% women; 46.7% white). Twenty-five (38.5%) patients had successfully discontinued their treatment for more than 6 months at their last visit. Median disease duration was 18 years (IQR, 10-23 years) in the group off treatment, compared to 9 years (IQR, 5.3-16.0 years) in the group still on treatment (P = 0.004). Renal artery involvement was less frequent in patients who had stopped their immunosuppressants, especially left renal artery (P = 0.035). Median CRP level at diagnosis was 16.4 mg/L (IQR, 5.4-32.2 mg/L) in the group off treatment, and 45 mg/L (IQR, 15.0-75.5 mg/L) in the group on treatment (P = 0.023). No other difference was found when comparing disease characteristics of the two groups, on or off medications.One third of TA patients were able to discontinue their treatment. They had lower CRP levels at diagnosis, less frequent renal artery involvement and longer disease duration. No other specific disease features seem to help identify patients with greater chances to be weaned off treatment successfully." @default.
- W4205156728 created "2022-01-25" @default.
- W4205156728 creator A5055599709 @default.
- W4205156728 creator A5075309120 @default.
- W4205156728 creator A5081031846 @default.
- W4205156728 date "2022-02-01" @default.
- W4205156728 modified "2023-10-16" @default.
- W4205156728 title "Cessation of immunosuppressive therapies in patients with Takayasu arteritis with sustained inactive disease" @default.
- W4205156728 cites W1926345360 @default.
- W4205156728 cites W1981729580 @default.
- W4205156728 cites W2007120498 @default.
- W4205156728 cites W2031517139 @default.
- W4205156728 cites W2044258895 @default.
- W4205156728 cites W2083370566 @default.
- W4205156728 cites W2588552224 @default.
- W4205156728 cites W2735854936 @default.
- W4205156728 cites W2737750524 @default.
- W4205156728 cites W2751645711 @default.
- W4205156728 cites W2758012671 @default.
- W4205156728 cites W2767834432 @default.
- W4205156728 cites W2886766341 @default.
- W4205156728 cites W2887722431 @default.
- W4205156728 cites W2952995727 @default.
- W4205156728 cites W2954943567 @default.
- W4205156728 cites W2973575493 @default.
- W4205156728 cites W2980408649 @default.
- W4205156728 cites W3023895973 @default.
- W4205156728 cites W3099784733 @default.
- W4205156728 cites W4238228430 @default.
- W4205156728 doi "https://doi.org/10.1016/j.semarthrit.2021.12.005" @default.
- W4205156728 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35000787" @default.
- W4205156728 hasPublicationYear "2022" @default.
- W4205156728 type Work @default.
- W4205156728 citedByCount "0" @default.
- W4205156728 crossrefType "journal-article" @default.
- W4205156728 hasAuthorship W4205156728A5055599709 @default.
- W4205156728 hasAuthorship W4205156728A5075309120 @default.
- W4205156728 hasAuthorship W4205156728A5081031846 @default.
- W4205156728 hasConcept C126322002 @default.
- W4205156728 hasConcept C141071460 @default.
- W4205156728 hasConcept C167135981 @default.
- W4205156728 hasConcept C2776015282 @default.
- W4205156728 hasConcept C2778715236 @default.
- W4205156728 hasConcept C2779134260 @default.
- W4205156728 hasConcept C2779291185 @default.
- W4205156728 hasConcept C2781343717 @default.
- W4205156728 hasConcept C3019145103 @default.
- W4205156728 hasConcept C71924100 @default.
- W4205156728 hasConcept C72563966 @default.
- W4205156728 hasConceptScore W4205156728C126322002 @default.
- W4205156728 hasConceptScore W4205156728C141071460 @default.
- W4205156728 hasConceptScore W4205156728C167135981 @default.
- W4205156728 hasConceptScore W4205156728C2776015282 @default.
- W4205156728 hasConceptScore W4205156728C2778715236 @default.
- W4205156728 hasConceptScore W4205156728C2779134260 @default.
- W4205156728 hasConceptScore W4205156728C2779291185 @default.
- W4205156728 hasConceptScore W4205156728C2781343717 @default.
- W4205156728 hasConceptScore W4205156728C3019145103 @default.
- W4205156728 hasConceptScore W4205156728C71924100 @default.
- W4205156728 hasConceptScore W4205156728C72563966 @default.
- W4205156728 hasLocation W42051567281 @default.
- W4205156728 hasLocation W42051567282 @default.
- W4205156728 hasOpenAccess W4205156728 @default.
- W4205156728 hasPrimaryLocation W42051567281 @default.
- W4205156728 hasRelatedWork W1207610165 @default.
- W4205156728 hasRelatedWork W1507742467 @default.
- W4205156728 hasRelatedWork W1964020670 @default.
- W4205156728 hasRelatedWork W1999304143 @default.
- W4205156728 hasRelatedWork W2053038853 @default.
- W4205156728 hasRelatedWork W2077424247 @default.
- W4205156728 hasRelatedWork W2296453903 @default.
- W4205156728 hasRelatedWork W2327677831 @default.
- W4205156728 hasRelatedWork W4205156728 @default.
- W4205156728 hasRelatedWork W3197783966 @default.
- W4205156728 hasVolume "52" @default.
- W4205156728 isParatext "false" @default.
- W4205156728 isRetracted "false" @default.
- W4205156728 workType "article" @default.